Patents Assigned to Dermatools Biotech GmbH
  • Patent number: 7582725
    Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin ?v?3 is inhibited.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: September 1, 2009
    Assignee: Dermatools Biotech GmbH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser